Meet Our Staff
Topics in This Section
By The Numbers
National rankings, accreditations, awards. The numbers are in your favor.
Read more »
Collection and distribution of human subject biosamples.
Read more »
Phase 1 Clinical Trials
Read more »
The Office of Research & Development Alliances supports the newly restated mission of Fox Chase Cancer Center to prevail over cancer, marshaling heart and mind in bold scientific discovery, pioneering prevention, and compassionate care by facilitating relationships with industry in order to translate clinical and basic research findings into products and services for the public good. Meet the Fox Chase Cancer Center Tech Transfer team.
Kurt A. Schwinghammer
Kurt A. Schwinghammer joined FCCC in April 2007 and became VP of the R&D Alliances Office in September 2009. He works closely with the Office of the President including all "C-level" executives to develop a strategy to effectively capitalize on Fox Chase's preclinical and clinical research capabilities. Kurt is pivotal in the development of preclinical and clinical strategic alliances with industry, and the development of all such business relationships. Among countless Kurt’s achievements he established Fox Chase International to initiate and maintain relationships with off-shore hospitals that require greater oncology skills, expertise and training; and serves as an active board member of two Fox Chase start-up companies: Dynamis Therapeutics and Nexus Pharmaceuticals. Read More »
Inna Khartchenko is Director of Licensing and Associate Director of the Office of Research and Development Alliances. Inna is a seasoned technology transfer professional with 15 years of experience in technology commercialization and licensing intellectual property. Prior to joining Fox Chase in 2007, Inna was Interim Director of the Office of Technology Transfer at Temple University. She received her MBA degree from Virginia Commonwealth University and her Master’s degree in Biochemistry and Molecular Biology from Saint Petersburg State University. Inna has in-depth knowledge of the technology commercialization process and intellectual property law, extensive experience in marketing technologies, forming R&D collaborative relationships with biotech and pharma companies, negotiating license deals and other technology development agreements, as well as identifying opportunities for creation of start-up companies, advising inventors on early steps of start-up development, and recruiting qualified management for portfolio start-ups.
Sayanti Saha, PhD joined the Research & Development Alliances team as a Contracts and Business Development Specialist in October 2012. In her job role, she promotes the commercialization of intellectual property, markets and licenses technologies and tangible research materials from Fox Chase Cancer Center (FCCC) research laboratories to pharmaceutical and biotechnology companies. Before joining the team full time, Sayanti worked as an intern in the department for 2 years. Alongside her internship, she concluded a postdoctoral fellowship at FCCC, where she focused her research on breast cancer and protein ubiquitination. As a scientist, Sayanti has authored and co-authored a number of articles in leading peer-reviewed journals. Sayanti holds a PhD from Indian Institute of Science (IISc), Bangalore, India. She is currently pursuing MBA from Fox School of Business, Temple University, Philadelphia, PA..
Julie Sharp, originally from the United Kingdom, been a member of the Fox Chase family since 2001. She is the Executive Administrative Assistant for the R&D alliances team, and oversees the day to day management of the R&D office. Some of her duties include managing the technology and patent database, filing system and recordation of agreements.
Jim Thompson, Director of Clinical Trials Contracting, has been a member of the Fox Chase family since 2007. Drawing on diverse skills and extensive experience in the medical device and pharmaceutical industry, Jim is uniquely qualified to assess the needs of both study sponsors and contract research organizations. His expertise in clinical trial planning, finance, and interpersonal skills serve our patients, clients, and institution well. Jim holds an MBA from Saint Joseph’s University in Philadelphia, a certificate in pharmaceutical medical writing from the American Medical Writers Association (AMWA), and is certified by Model Agreements & Guidelines International (MAGI) as a Clinical Research Contract Professional (CRCP).
Johana Vanegas, originally from the Colombia, received her medical degree in Bogotá, from La Fundación Universitaria Juan N. Corpas in December 2000. Johana first joined FCCC in 2002, and devoted eight years to breast cancer research at the Breast Cancer Research Laboratory. Her interest in business moved her to pursue an MBA at Temple University, and transfer to the Office of R&D Alliances in July 2011, were she holds the position of Business Development Manager. In her new role Johana creates and implements recommendations on business development strategy, acts as a point of contact for introductory meetings with industry, and evaluates opportunities within market dynamics and assesses strategic implications for FCCC.
Marianne Weyhmuller, Sr. Contracts Specialist joined Fox Chase Cancer Center in 1989. Marianne has been an integral component of the Office of Corporate Alliances for the past 18+ years. She draws on her diverse skills and experience to perform contract review and negotiation in Sponsored Research, Confidentiality, Consulting, Material Transfer, Software and a wide variety of miscellaneous agreements with a clinical and academic focus.
Rikki Renz joined the Research & Development Alliances team at Fox Chase Cancer Center as a Contracts Specialist in July 2013 and works under Jim Thompson. Rikki performs legal and business terms contract review, budget development and negotiation and assists in managing the clinical trial database. Her previous experience within various legal departments as a Transactional Paralegal and Contract Manager, within the pharmaceutical and banking industries, creates a unique approach and insight into contracts.
Christina Mitala, Ph.D.
Christina Mitala, Ph.D., joined Fox Chase Cancer Center in 2013 as a Contracts Specialist. Dr. Mitala came to Fox Chase Cancer Center after holding positions in technology transfer at the National Cancer Institute and the National Institute of Dental and Craniofacial Research, both institutes of the National Institutes of Health (NIH). Dr. Mitala is proficient in contract negotiation for both for-profit companies and research institutes and has successfully executed various agreements with them. She also has a deep understanding of managing technology transfer portfolios, marketing/licensing technologies, and developing educational technology transfer programs for investigators. At Fox Chase, Dr. Mitala focuses her efforts on executing Clinical Trial Agreements and Budgets funded primarily by industry. Dr. Mitala is committed to driving business forward while continuing to build positive relationships with her clients. Dr. Mitala holds a Ph.D. in Chemistry from the University of Pittsburgh and has completed post-doctoral training in Neurology at The Children’s Hospital of Philadelphia.